Sci Rep 11(1):11107 Acknowledgements We are grateful to our Department of Human Genetics, Sri Ramachandra Institute of Higher Education and Research
Taking 1 mL working solution as an example, add 100 L DMSO stock solution ( 20.8 mg/mL ) to 400 L PEG300 , and mix evenly
Semaglutide is an FDA-approved GLP-1 receptor agonist that reduces hunger signalling, delays gastric emptying, and produces mean body weight reductions of 14.9% over 68 weeks in clinical trials
GLP-1 receptor agonists are revolutionizing the treatment of type 2 diabetes and obesity
Fragile X Syndrome, another NDD that is characterized by intellectual disability (ID) among other symptoms, has high comorbidity with ASD and is a result of a CGG triplet repeat expansion mutation in the fragile X mental retardation 1 gene ( FMR1 ) that silences the production of its encoded FMRP protein [45, 46]
GLP-1 medications have become one of the most talked-about tools in modern weight managementbut with increased visibility comes misinformation